UPDF AI

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19

L. Bowles,S. Platton,8 Authors,P. Maccallum

2020 · DOI: 10.1056/NEJMc2013656
New England Journal of Medicine · 443 Citations

TLDR

Prolonged aPTT in patients with Covid-19 had a prolonged activated partial-thromboplastin time and the cause was lupus anticoagulant...

Abstract

Prolonged aPTT in Patients with Covid-19 In this study, 20% of patients with Covid-19 had a prolonged activated partial-thromboplastin time. In 90% of these cases, the cause was lupus anticoagulant...